Intrapleural hypotonic cisplatin treatment for malignant pleural effusion in 80 patients with non-small-cell lung cancer: A multi-institutional phase II trial

British Journal of Cancer

Volumn 95, Issue 6, 2006, Pages 717-721

  Seto, T ^a,g   Ushijima, S ^b   Yamamoto, H ^c   Ito, K ^d   Araki, J ^e   Inoue, Y ^f   Semba, H ^g   Ichinose, Y ^a   Yamaguchi, Kyushu ^h  

^a NATIONAL KYUSHU CANCER CENTER   (Japan)

^b Kumamoto Central Hospital   (Japan)

^c ASO IIZUKA HOSPITAL   (Japan)

^d Shinbeppu Hospital   (Japan)

^e Yamaguchi Central Hospital   (Japan)

^f Isahaya Insurance General Hospital   (Japan)

^g KUMAMOTO REGIONAL MEDICAL CENTER   (Japan)

^h NONE

Author keywords

Hypotonic cisplatin treatment; Intrapleural chemotherapy; Malignant pleural effusion; Management of malignant pleural effusion; Non small cell lung cancer

Indexed keywords

CISPLATIN; HYPOTONIC SOLUTION;

ADULT; AGED; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYSPNEA; FEMALE; FEVER; HUMAN; INFECTION; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NAUSEA; PHASE 2 CLINICAL TRIAL; PLEURA EFFUSION; PLEURA EMPYEMA; PRIORITY JOURNAL; THORAX DRAINAGE; THORAX PAIN; TREATMENT RESPONSE; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; DISEASE PROGRESSION; DRUG ADMINISTRATION ROUTES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOTONIC SOLUTIONS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PLEURAL EFFUSION, MALIGNANT; PLEURAL NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33748521871     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603319     Document Type: Article

References (22)

1. Chernow B, Sahn SA (1977) Carcinomatous involvement of the pleura: an analysis of 96 patients. Am J Med 63: 695-702
2. Desai SD, Figueredo A (1979) Intracavitary doxorubicin in malignant effusions. Lancet 1: 872 (letter)
3. Hartman DL, Gaither JM, Kesler KA, Mylet DM, Brown JW, Mathur PN (1993) Comparison of insufflated talc under thoracoscopic guidance with standard tetracycline and bleomycin pleurodesis for control of malignant pleural effusions. J Thorac Cardiovasc Surg 105: 743-747 (discussion 747-748)
4. Hausheer FH, Yarbro JW (1985) Diagnosis and treatment of malignant pleural effusion. Semin Oncol 12: 54-75
5. Holoye PY, Jeffries DG, Dhingra HM, Holmes FA, Raber M, Engineer MS, Newman RA (1990) Intrapleural etoposide for malignant effusion. Cancer Chemother Pharmacol 26: 147-150
6. Ichinose Y, Hara N, Ohta M, Asoh H, Yano T, Maeda K, Yagawa K (1993) Hypotonic cisplatin treatment for carcinomatous pleuritis found at thoracotomy in patients with lung cancer. In vitro experiments and preliminary clinical results. J Thorac Cardiovasc Surg 105: 1041-1046
7. Ichinose Y, Tsuchiya R, Koike T, Yasumitsu T, Nakamura K, Tada H, Yoshimura H, Mitsudomi T, Nakagawa K, Yokoi K, Kato H (2002) A prematurely terminated phase III trial of intraoperative intrapleural hypotonic cisplatin treatment in patients with resected non-small cell lung cancer with positive pleural lavage cytology: the incidence of carcinomatous pleuritis after surgical intervention. J Thorac Cardiovasc Surg 123: 695-699
8. Ichinose Y, Yano T, Asoh H, Yokoyama H, Fukuyama Y, Miyagi J, Kuninaka S, Terazaki Y (1997) Intraoperative intrapleural hypotonic cisplatin treatment for carcinomatous pleuritis. J Surg Oncol 66: 196-200
9. Luh KT, Yang PC, Kuo SH, Chang DB, Yu CJ, Lee LN (1992) Comparison of OK-432 and mitomycin C pleurodesis for malignant pleural effusion caused by lung cancer. A randomized trial. Cancer 69: 674-679
10. Moffett MJ, Ruckdeschel JC (1992) Bleomycin and tetracycline in malignant pleural effusions: a review. Semin Oncol 19: 59-62 (discussion 62-53)
11. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5: 649-655
12. Putnam Jr JB, Light RW, Rodriguez RM, Ponn R, Olak J, Pollak JS, Lee RB, Payne DK, Graeber G, Kovitz KL (1999) A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions. Cancer 86: 1992-1999
13. Rosenberg B (1978) Platinum complex-DNA interactions and anticancer activity. Biochimie 60: 859-867
14. Ruckdeschel JC, Moores D, Lee JY, Einhorn LH, Mandelbaum I, Koeller J, Weiss GR, Losada M, Keller JH (1991) Intrapleural therapy for malignant pleural effusions. A randomized comparison of bleomycin and tetracycline. Chest 100: 1528-1535
15. Rusch VW, Figlin R, Godwin D, Piantadosi S (1991) Intrapleural cisplatin and cytarabine in the management of malignant pleural effusions: a Lung Cancer Study Group trial. J Clin Oncol 9: 313-319
16. Saka H, Shimokata K, Watanabe A, Saito H, Minami H, Sakai S (1994) Randomized comparision of OK-432 and bleomycin in intrapleural therapy for malignant pleural effusion. Proc Am Soc Clin Oncol 13: 450
17. Shan SA (1987) Malignant pleural effusion. Semin Respir Med 9: 43-53
18. Sherman SE, Lippard SJ (1987) Structural aspects of platinum anticancer drug interactions with DNA. Chem Rev 87: 1153-1181
19. Suhrland LG, Weisberger AS (1965) Intracavity 5-fluorouracil in malignant effusion. Arch Intern Med 116: 431-433
20. Tohda Y, Iwanaga T, Takada M, Yana T, Kawahara M, Negoro S, Okishio K, Kudoh S, Fukuoka M, Furuse K (1999) Intrapleural administration of cisplatin and etoposide to treat malignant pleural effusions in patients with non-small cell lung cancer. Chemotherapy 45: 197-204
21. Ushijima S, Nakamoto K, Ueda K (1997) Experiment of hypotonic cisplatin treatment for malignant pleural effusion. Kyoubu Shikkan Gakkai Zasshi 35(Suppl): 310 (Japanese)
22. Walker-Renard PB, Vaughan LM, Sahn SA (1994) Chemical pleurodesis for malignant pleural effusions. Ann Intern Med 120: 56-64